Last 12 months
Inside the activity.
1 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 1 | 25 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 20 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 21 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 22, 2021 Filed Nov 24, 2021 21:08 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 643 | $0.99 | $637.79 |
DisclosureSEC source: 0001567619-21-021165 · doc1.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,161 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:06 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 2,607 | $0.99 | $2,585.88 |
DisclosureSEC source: 0001567619-21-021162 · doc1.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631,803 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:05 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 537 | $0.99 | $532.65 |
DisclosureSEC source: 0001567619-21-021158 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,958 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:06 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
SaleCommon Stock | 754 | $0.99 | $747.89 |
DisclosureSEC source: 0001567619-21-021161 · doc1.xml · nonDerivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,483 F3 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:06 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
SaleCommon Stock | 5,000 | $0.98 | $4,881.50 |
DisclosureSEC source: 0001567619-21-021161 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,237 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021. F2 · price: This transaction was executed in multiple trades in prices ranging from $0.96 to $0.992, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 22:54 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
SaleCommon Stock | 5,000 | $1.13 | $5,650.00 |
DisclosureSEC source: 0001567619-21-020591 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,237 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021. Read SEC document |
| November 12, 2021 Filed Nov 13, 2021 00:09 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 77,432 | $1.13 | $87,111.00 |
DisclosureSEC source: 0001567619-21-020115 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,495 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 28, 2021. F2 · price: The transaction was executed in multiple trades in prices ranging from $1.11 to $1.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:17 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
SaleCommon Stock | 2,166 | $1.18 | $2,555.88 |
DisclosureSEC source: 0001567619-21-019728 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,237 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021. F2 · balance_after: Reflects the adjusted total which includes the purchase of 2,166 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021. F3 · balance_after: Reflects the adjusted total which includes the purchase of 2,540 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021. Read SEC document |
| October 08, 2021 Filed Oct 29, 2021 19:56 UTC |
Rodriguez SusanChief Commercial Officer
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019031 · doc1.xml · nonDerivative · entry 1 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,673 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021. Read SEC document |
| October 08, 2021 Filed Oct 29, 2021 23:57 UTC |
Rosenbaum David P.Chief Development Officer
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019032 · doc1.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 90,811 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021. F3 · balance_after: Reflects the adjusted total which includes the purchase of 1,237 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021. F4 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| October 08, 2021 Filed Oct 29, 2021 23:57 UTC |
Rosenbaum David P.Chief Development Officer
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019032 · doc1.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,804 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021. Read SEC document |
| October 08, 2021 Filed Oct 29, 2021 19:56 UTC |
Blanks RobertSee Remarks
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019030 · doc1.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,511 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · balance_after: Reflects the adjusted total which includes the purchase of 2,188 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021. F3 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021. Read SEC document |
| October 08, 2021 Filed Oct 29, 2021 19:55 UTC |
Renz Justin AChief Financial Officer
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019029 · doc1.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,330 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,283 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021. F3 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021. Read SEC document |
| October 08, 2021 Filed Oct 29, 2021 23:58 UTC |
RAAB MICHAELDirector · President & CEO
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019033 · doc1.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,410 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,937 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021. F3 · balance_after: Reflects the adjusted total which includes the purchase of 2,743 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021. Read SEC document |
| October 08, 2021 Filed Oct 29, 2021 23:54 UTC |
GRAMMER ELIZABETH ASee Remarks
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019028 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,927 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,541 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 18:07 UTC |
Rodriguez SusanChief Commercial Officer
|
SaleCommon Stock | 630 | $1.32 | $831.60 |
DisclosureSEC source: 0001567619-21-016286 · doc1.xml · nonDerivative · entry 1 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,673 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 18:05 UTC |
Blanks RobertSee Remarks
|
SaleCommon Stock | 631 | $1.32 | $832.92 |
DisclosureSEC source: 0001567619-21-016281 · doc1.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,323 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 18:07 UTC |
Renz Justin AChief Financial Officer
|
SaleCommon Stock | 631 | $1.32 | $832.92 |
DisclosureSEC source: 0001567619-21-016285 · doc1.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,047 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:08 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 176 | $1.32 | $232.32 |
DisclosureSEC source: 0001567619-21-016287 · doc1.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 26,574 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:08 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 631 | $1.32 | $832.92 |
DisclosureSEC source: 0001567619-21-016287 · doc1.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,804 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:06 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 2,573 | $1.32 | $3,396.36 |
DisclosureSEC source: 0001567619-21-016284 · doc1.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,730 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:06 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
SaleCommon Stock | 741 | $1.32 | $978.12 |
DisclosureSEC source: 0001567619-21-016283 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,697 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:05 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 526 | $1.32 | $694.32 |
DisclosureSEC source: 0001567619-21-016282 · doc1.xml · nonDerivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,386 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:01 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 267,892 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001567619-21-014511 · doc1.xml · derivative · entry 5 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 267,892 shares Expires 2021-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:01 UTC |
RAAB MICHAELDirector · President & CEO
|
Tax withholdingCommon Stock | 150,343 | $1.64 | $246,562.52 |
DisclosureSEC source: 0001567619-21-014511 · doc1.xml · nonDerivative · entry 2 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,303 F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were granted in August 2011 and set to expire on August 11, 2021. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:01 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionCommon Stock | 267,892 | $0.54 | $144,661.68 |
DisclosureSEC source: 0001567619-21-014511 · doc1.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:00 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001567619-21-014510 · doc1.xml · derivative · entry 3 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:00 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
Tax withholdingCommon Stock | 5,613 | $1.64 | $9,205.32 |
DisclosureSEC source: 0001567619-21-014510 · doc1.xml · nonDerivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,438 F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were granted in August 2011 and set to expire on August 11, 2021. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:00 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.54 | $5,400.00 |
DisclosureSEC source: 0001567619-21-014510 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:09 UTC |
Cadoret-Manier OnaizaDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,765 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001567619-21-012428 · doc1.xml · derivative · entry 1 Cadoret-Manier Onaiza · CIK 0001799355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,765 Underlying: Common Stock · 32,765 shares Expires 2031-06-16 F1 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F2 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 16:08 UTC |
Lundberg Jan MDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,765 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001567619-21-012427 · doc1.xml · derivative · entry 2 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,765 Underlying: Common Stock · 32,765 shares Expires 2031-06-16 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 16:08 UTC |
Lundberg Jan MDirector
|
GrantCommon Stock | 7,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-012427 · doc1.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,799 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:11 UTC |
Bertrand William C JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,765 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001567619-21-012431 · doc1.xml · derivative · entry 2 Bertrand William C JR · CIK 0001291937 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,765 Underlying: Common Stock · 32,765 shares Expires 2031-06-16 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:11 UTC |
Bertrand William C JRDirector
|
GrantCommon Stock | 8,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-012431 · doc1.xml · nonDerivative · entry 1 Bertrand William C JR · CIK 0001291937 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,549 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:10 UTC |
Bazemore Robert BDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,765 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001567619-21-012430 · doc1.xml · derivative · entry 1 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,765 Underlying: Common Stock · 32,765 shares Expires 2031-06-16 F1 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F2 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:10 UTC |
Rodgers Richard JDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,765 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001567619-21-012429 · doc1.xml · derivative · entry 2 Rodgers Richard J · CIK 0001313397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,765 Underlying: Common Stock · 32,765 shares Expires 2031-06-16 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:10 UTC |
Rodgers Richard JDirector
|
GrantCommon Stock | 9,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-012429 · doc1.xml · nonDerivative · entry 1 Rodgers Richard J · CIK 0001313397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,527 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:08 UTC |
Block Geoffrey A.Director
|
GrantStock Option (Right to Buy) · Derivative | 32,765 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001567619-21-012426 · doc1.xml · derivative · entry 1 Block Geoffrey A. · CIK 0001770782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,765 Underlying: Common Stock · 32,765 shares Expires 2031-06-16 F1 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F2 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:07 UTC |
MOTT DAVID MDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,765 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001567619-21-012425 · doc1.xml · derivative · entry 1 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,765 Underlying: Common Stock · 32,765 shares Expires 2031-06-16 F1 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F2 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:32 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001567619-21-012329 · doc1.xml · derivative · entry 3 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 7,500 shares Expires 2021-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. F3 · derivative.exercise_date: The option, which was granted on August 11, 2011 and has an expiration date of August 11, 2021, is fully vested and exercisable. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:32 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
SaleCommon Stock | 7,500 | $7.29 | $54,658.50 |
DisclosureSEC source: 0001567619-21-012329 · doc1.xml · nonDerivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,051 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. F2 · price: This transaction was executed in multiple trades in prices ranging from $7.242 to $7.41, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:32 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
Exercise / conversionCommon Stock | 7,500 | $0.54 | $4,050.00 |
DisclosureSEC source: 0001567619-21-012329 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 23:23 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 3,062 | $7.22 | $22,098.15 |
DisclosureSEC source: 0001567619-21-011569 · doc1.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 26,750 F1 · price: The transaction was executed in multiple trades in prices ranging from $7.215 to $7.221, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:49 UTC |
Rodriguez SusanChief Commercial Officer
|
SaleCommon Stock | 611 | $7.09 | $4,330.65 |
DisclosureSEC source: 0001567619-21-010924 · doc1.xml · nonDerivative · entry 1 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,303 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:46 UTC |
Blanks RobertSee Remarks
|
SaleCommon Stock | 612 | $7.09 | $4,337.73 |
DisclosureSEC source: 0001567619-21-010918 · doc1.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,954 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:48 UTC |
Renz Justin AChief Financial Officer
|
SaleCommon Stock | 612 | $7.09 | $4,337.73 |
DisclosureSEC source: 0001567619-21-010923 · doc1.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,678 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:49 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 157 | $7.09 | $1,112.78 |
DisclosureSEC source: 0001567619-21-010925 · doc1.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 29,812 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:49 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 612 | $7.09 | $4,337.73 |
DisclosureSEC source: 0001567619-21-010925 · doc1.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,435 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:47 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 2,534 | $7.09 | $17,960.49 |
DisclosureSEC source: 0001567619-21-010922 · doc1.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,754 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:47 UTC |
Jacobs Jeffrey WChief Scientific Officer
|
SaleCommon Stock | 721 | $7.09 | $5,110.30 |
DisclosureSEC source: 0001567619-21-010921 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,051 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F1 · shares: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.